The active substance fluxapyroxad, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Art. 1 Commission Implementing Regulation (EU) No 589/2012 of 4 July 2012 approving the active…
Approval of active substance
In forcesince 4 Jul 2012